Synopsis
Synopsis
0
VMF
0
Australia
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. Cleocin Phosphate
2. Clindamycin-2-phosphate
3. Clindesse
4. Clindets
1. 24729-96-2
2. Cleocin Phosphate
3. Clindamycin 2-phosphate
4. Clindets
5. Cleocin T
6. Clindagel
7. Clindesse
8. Evoclin
9. Clinda-derm
10. Dalacin P
11. Clindamycin-2-phosphate
12. Clindamycin 2-dihydrogen Phosphate
13. Clindamycin (phosphate)
14. Dalacin T
15. 7(s)-chloro-7-deoxylincomycin 2-phosphate
16. U 28508
17. U-28508
18. U-28,508
19. Eh6d7113i8
20. Nsc 618653
21. Nsc-618653
22. Dsstox_cid_28603
23. Dsstox_rid_82873
24. Dsstox_gsid_48677
25. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propylpyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyloxan-3-yl] Dihydrogen Phosphate
26. Clindamax
27. Evoclin (tn)
28. Dalacin-s (tn)
29. Clindamycin Injection
30. Cas-24729-96-2
31. Einecs 246-433-0
32. Clindamycin Phosphate Hydrate [jan]
33. Clindamycin Dihydrogenphosphat
34. Clinadac
35. Unii-eh6d7113i8
36. Clindamycin Phosphate Hydrate
37. Clindamycin Phosphate In Dextrose 5%
38. Clindamycin-2-dihydrogenphosphat
39. Ncgc00163494-01
40. Ncgc00166320-01
41. Clindamycin-phosphate
42. Clindac
43. Xaciato
44. Clindamycin Phosphate [usan:usp:jan]
45. Cleocin Phosphate In Dextrose 5% In Plastic Container
46. Clindamycin Phosphate In Dextrose 5% In Plastic Container
47. Schembl37148
48. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-alpha-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
49. Chembl3184512
50. Dtxsid1048677
51. Bdbm241975
52. Clindamycin (as Phosphate)
53. Clindamycin Phosphate (jp17/usp)
54. Clindamycin Phosphate [jan]
55. Hy-b1064
56. Zinc4102185
57. Clindamycin Phosphate [usan]
58. Tox21_113055
59. Tox21_113410
60. Clindamycin Phosphate (u-28508e)
61. Clindamycin Phosphate [vandf]
62. Mfcd11982855
63. S2048
64. Clindamycin Phosphate [mart.]
65. Akos008901431
66. Clindamycin Phosphate [usp-rs]
67. Clindamycin Phosphate [who-dd]
68. Clindamycin Phosphate [who-ip]
69. Ccg-269736
70. Clindamycin Phosphate System Suitability
71. Cs-4620
72. Ncgc00386379-01
73. As-12554
74. L-threo-alpha-d-galacto-octapyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
75. Methyl (2s-trans)-7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-l-threo-alpha-d-galacto-octopyranoside, 2-(dihydrogen Phosphate)
76. Clindamycin Phosphate [orange Book]
77. Duac Component Clindamycin Phosphate
78. Clindamycin Phosphate [ep Monograph]
79. Clindamycin Phosphate For System Suitability
80. Ziana Component Clindamycin Phosphate
81. Acanya Component Clindamycin Phosphate
82. Clindamycin Phosphate [usp Monograph]
83. Clindamycini Phosphas [who-ip Latin]
84. Veltin Component Clindamycin Phosphate
85. Clindamycin Phosphate Component Of Duac
86. Benzaclin Component Clindamycin Phosphate
87. Clindamycin 2-dihydrogen Phosphate [mi]
88. Clindamycin Phosphate Component Of Ziana
89. D01073
90. Idp-126 Component Clindamycin Phosphate
91. Ab01566857_01
92. Clindamycin Phosphate Component Of Acanya
93. Clindamycin Phosphate Component Of Veltin
94. A817470
95. Clindamycin Phosphate Component Of Benzaclin
96. Sr-01000872581
97. Sr-01000872581-1
98. Brd-k27771035-001-02-5
99. Q27106184
100. Clindamycin Phosphate System Suitability [usp-rs]
101. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yl Dihydrogen Phosphate
102. (2r,3r,4s,5r,6r)-6-((1s,2s)-2-chloro-1-((2s,4r)-1-methyl-4-propylpyrrolidine-2-carboxamido)propyl)-4,5-dihydroxy-2-(methylthio)tetrahydro-2h-pyran-3-yldihydrogenphosphate
103. (2s-trans)-methyl 7-chloro-6,7,8-trideoxy-6-[[(1-methyl-4-propyl-2-pyrrolidinyl)carbonyl]amino]-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
104. [(2r,3r,4s,5r,6r)-6-[(1s,2s)-2-chloro-1-[[(2s,4r)-1-methyl-4-propyl-pyrrolidine-2-carbonyl]amino]propyl]-4,5-dihydroxy-2-methylsulfanyl-tetrahydropyran-3-yl] Dihydrogen Phosphate
105. [(2r,4r,5r)-6-[(2s)-2-chloro-1-[[[(2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl]-oxomethyl]amino]propyl]-4,5-dihydroxy-2-(methylthio)-3-oxanyl] Dihydrogen Phosphate
106. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-((((2s,4r)-1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate)
107. L-threo-.alpha.-d-galacto-octopyranoside, Methyl 7-chloro-6,7,8-trideoxy-6-(((1-methyl-4-propyl-2-pyrrolidinyl)carbonyl)amino)-1-thio-, 2-(dihydrogen Phosphate), (2s-trans)-
108. Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-l-2-pyrrolidinecarboxamido)-1-thio-l-threo-.alpha.-d-galacto-octopyranoside 2-(dihydrogen Phosphate)
Molecular Weight | 505.0 g/mol |
---|---|
Molecular Formula | C18H34ClN2O8PS |
XLogP3 | -1.2 |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 10 |
Rotatable Bond Count | 9 |
Exact Mass | 504.1462019 g/mol |
Monoisotopic Mass | 504.1462019 g/mol |
Topological Polar Surface Area | 174 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 658 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
1 of 12 | |
---|---|
Drug Name | Cleocin phosphate |
Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 150mg base/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
2 of 12 | |
---|---|
Drug Name | Cleocin t |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Gel; Lotion; Solution |
Route | Topical |
Strength | eq 1% base |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
3 of 12 | |
---|---|
Drug Name | Clindagel |
Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Gel |
Route | Topical |
Strength | eq 1% base |
Market Status | Prescription |
Company | Precision Dermat |
4 of 12 | |
---|---|
Drug Name | Clindamycin phosphate |
PubMed Health | Clindamycin (Injection) |
Drug Classes | Antibiotic, Antimalarial |
Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
Route | Topical; Injection; Vaginal |
Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
Market Status | Prescription |
Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
5 of 12 | |
---|---|
Drug Name | Clindesse |
Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Cream |
Route | Vaginal |
Strength | eq 2% base |
Market Status | Prescription |
Company | Lumara Health |
6 of 12 | |
---|---|
Drug Name | Clindets |
Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Swab |
Route | Topical |
Strength | eq 1% base |
Market Status | Prescription |
Company | Perrigo |
7 of 12 | |
---|---|
Drug Name | Cleocin phosphate |
Drug Label | CLEOCIN PHOSPHATE Sterile Solution in vials contains clindamycin phosphate, a water soluble ester of clindamycin and phosphoric acid. Each mL contains the equivalent of 150 mg clindamycin, 0.5 mg disodium edetate and 9.45 mg benzyl alcohol added as p... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Injectable |
Route | Injection |
Strength | eq 150mg base/ml |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
8 of 12 | |
---|---|
Drug Name | Cleocin t |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Gel; Lotion; Solution |
Route | Topical |
Strength | eq 1% base |
Market Status | Prescription |
Company | Pharmacia And Upjohn |
9 of 12 | |
---|---|
Drug Name | Clindagel |
Drug Label | Clindagel (clindamycin phosphate gel) topical gel, 1%, a topical antibiotic, contains clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per gram in a gel vehicle consisting of carbomer 941, methylparaben, polyethylene g... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Gel |
Route | Topical |
Strength | eq 1% base |
Market Status | Prescription |
Company | Precision Dermat |
10 of 12 | |
---|---|
Drug Name | Clindamycin phosphate |
PubMed Health | Clindamycin (Injection) |
Drug Classes | Antibiotic, Antimalarial |
Drug Label | Clindamycin Injection, USP, a water soluble ester of clindamycin and phosphoric acid, is a sterile solution for intramuscular or intravenous use.May contain sodium hydroxide and/or hydrochloric acid for pH adjustment. pH is 6.5 range 5.5to 7.0.Clin... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Lotion; Gel; Swab; Injectable; Cream; Aerosol, foam; Solution |
Route | Topical; Injection; Vaginal |
Strength | eq 1% base; 1%; eq 150mg base/ml; eq 2% base |
Market Status | Prescription |
Company | Wockhardt; Sagent Strides; Bedford; Fougera Pharms; Fresenius Kabi Usa; Hospira; Hikma Maple; Versapharm; Perrigo Uk Finco; Perrigo New York; Taro Pharm Inds; Fougera; G And W Labs |
11 of 12 | |
---|---|
Drug Name | Clindesse |
Drug Label | CLEOCIN T Topical Solution and CLEOCIN T Topical Lotion contain clindamycin phosphate, USP, at a concentration equivalent to 10 mg clindamycin per milliliter. CLEOCIN T Topical Gel contains clindamycin phosphate, USP, at a concentration equivalent to... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Cream |
Route | Vaginal |
Strength | eq 2% base |
Market Status | Prescription |
Company | Lumara Health |
12 of 12 | |
---|---|
Drug Name | Clindets |
Drug Label | Clindamycin phosphate, a lincosamide, is a water soluble ester of the semi-synthetic antibiotic produced by a 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the parent antibiotic lincomycin. The chemical name for clindamycin phosphate is meth... |
Active Ingredient | Clindamycin phosphate |
Dosage Form | Swab |
Route | Topical |
Strength | eq 1% base |
Market Status | Prescription |
Company | Perrigo |
Anti-Bacterial Agents
Substances that inhibit the growth or reproduction of BACTERIA. (See all compounds classified as Anti-Bacterial Agents.)
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13705
Submission : 1998-09-01
Status : Inactive
Type : II
LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13725
Submission : 1998-09-01
Status : Inactive
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2013-02-12
Pay. Date : 2013-01-23
DMF Number : 14412
Submission : 1999-09-23
Status : Active
Type : II
Certificate Number : R1-CEP 2000-097 - Rev 05
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 996
Status : Valid
Registration Number : 226MF10069
Registrant's Address : Mallorca, 262, 3rd floor 08008 Barcelona Spain
Initial Date of Registration : 2014-03-11
Latest Date of Registration : --
NDC Package Code : 49711-0116
Start Marketing Date : 2009-10-22
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-11-30
Pay. Date : 2016-08-02
DMF Number : 17422
Submission : 2004-05-09
Status : Active
Type : II
Certificate Number : CEP 2003-060 - Rev 07
Issue Date : 2024-03-25
Type : Chemical
Substance Number : 996
Status : Valid
NDC Package Code : 39635-0001
Start Marketing Date : 2014-03-18
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24358
Submission : 2010-11-08
Status : Active
Type : II
Certificate Number : R1-CEP 2011-019 - Rev 01
Issue Date : 2018-06-13
Type : Chemical
Substance Number : 996
Status : Valid
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 32255
Submission : 2017-11-28
Status : Active
Type : II
Certificate Number : CEP 2022-145 - Rev 00
Issue Date : 2024-05-27
Type : Chemical
Substance Number : 996
Status : Valid
NDC Package Code : 69132-003
Start Marketing Date : 2017-09-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Clindamycin phosphate, Albano plant
Certificate Number : R1-CEP 2006-033 - Rev 04
Status : Valid
Issue Date : 2022-09-01
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 1999-025 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2007-06-15
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2005-033 - Rev 03
Status : Valid
Issue Date : 2023-01-17
Type : Chemical
Substance Number : 996
Clindamycin phosphate, Alternative process
Certificate Number : R1-CEP 2009-398 - Rev 04
Status : Valid
Issue Date : 2022-11-08
Type : Chemical
Substance Number : 996
Certificate Number : R0-CEP 2007-250 - Rev 01
Status : Withdrawn by EDQM Failure to CEP pro...
Issue Date : 2009-07-07
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2000-097 - Rev 05
Status : Valid
Issue Date : 2023-06-09
Type : Chemical
Substance Number : 996
Clindamycin phosphate, Product code number 60960
Certificate Number : R0-CEP 2003-177 - Rev 01
Status : Expired
Issue Date : 2010-01-14
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2011-019 - Rev 01
Status : Valid
Issue Date : 2018-06-13
Type : Chemical
Substance Number : 996
Certificate Number : R1-CEP 2000-256 - Rev 05
Status : Withdrawn by Holder
Issue Date : 2019-01-31
Type : Chemical
Substance Number : 996
Certificate Number : R0-CEP 2007-299 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2012-03-08
Type : Chemical
Substance Number : 996
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?